Lasso

SiriusXM Canada and CCMA announce eight semi-finalists in this year's Top of the Country competition

Retrieved on: 
Wednesday, February 21, 2024

"Country music has never been more popular than it is right now and the talent of our top eight is some of the best we've seen in the six years we've been holding the SiriusXM Top of the Country competition," said Michelle Mearns, VP of Programming & Operations, SiriusXM Canada.

Key Points: 
  • "Country music has never been more popular than it is right now and the talent of our top eight is some of the best we've seen in the six years we've been holding the SiriusXM Top of the Country competition," said Michelle Mearns, VP of Programming & Operations, SiriusXM Canada.
  • "This competition serves as a launching point for home-grown talent and is an opportunity for artists' dreams to be realized.
  • "The opportunity to celebrate the talent emerging from the SiriusXM Top of the Country competition is something we at the CCMA look forward to year after year," said Amy Jeninga, President, CCMA.
  • Through significant financial contributions and its extensive North American reach, SiriusXM continues to provide a premier platform for Canadian artists.

Kirby McInerney LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Reata Pharmaceuticals, Inc. Common Stock

Retrieved on: 
Monday, January 8, 2024

PLEASE READ THIS NOTICE CAREFULLY, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

Key Points: 
  • PLEASE READ THIS NOTICE CAREFULLY, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • YOU ARE ALSO NOTIFIED that Lead Plaintiff in the Action has reached a proposed settlement of the Action for $45,000,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement, should be directed to Lead Counsel or the Claims Administrator.

CHC brief questions FTC ad market definition in IQVIA merger challenge

Retrieved on: 
Wednesday, December 20, 2023

In July, the FTC issued an administrative complaint in federal court to block IQVIA from acquiring Propel Media alleging that the proposed acquisition would give the company a market-leading position in programmatic advertising for health care products, namely prescription drugs to health care professionals.

Key Points: 
  • In July, the FTC issued an administrative complaint in federal court to block IQVIA from acquiring Propel Media alleging that the proposed acquisition would give the company a market-leading position in programmatic advertising for health care products, namely prescription drugs to health care professionals.
  • From the FTC's complaint, which is significantly redacted to the public, CHC questioned the agency's narrow and antiquated view that Demand Side Platforms (DSPs) alone "provide programmatic advertising" to advertisers.
  • The CHC urged the court to reject the overly narrow view of "programmatic advertising" advanced by the FTC.
  • The brief was developed in collaboration with CHC and 4A's, and filed by Sidley Austin, LLP with attorneys from its New York and Washington, DC offices.

Lasso Security Emerges from Stealth With $6 Million Seed Funding to Pioneer Gen AI and Advanced LLM Cybersecurity

Retrieved on: 
Monday, November 20, 2023

TEL AVIV, Israel, Nov. 20, 2023 /PRNewswire/ -- Lasso Security, innovators in Large Language Models (LLMs) cybersecurity, today announced a $6 million seed round led by Entrée Capital with the participation of Samsung Next. Every few years there's a major technological revolution. In the 90s, it was the internet; in the 2010s, it was the cloud and most recently, we have Generative AI. The revolution that Gen AI and LLMs technologies have brought to organizations has been significantly embraced by hundreds of millions of end-users and hundreds of thousands of organizations. This swift adoption also presents a pressing issue - the significant cybersecurity challenges posed by LLMs, including data exposure, security and compliance risks. Lasso is setting the standard for LLM cybersecurity by safeguarding every LLM touchpoint, ensuring unrivaled, comprehensive protection for businesses leveraging Gen AI and other large language model technologies. The company intends to utilize the funds to expand its team and further enhance its offerings. 

Key Points: 
  • This swift adoption also presents a pressing issue - the significant cybersecurity challenges posed by LLMs, including data exposure, security and compliance risks.
  • Lasso is setting the standard for LLM cybersecurity by safeguarding every LLM touchpoint, ensuring unrivaled, comprehensive protection for businesses leveraging Gen AI and other large language model technologies.
  • Lasso Security's mission is focused on equipping Gen AI and LLM pioneers with innovative security solutions that allow organizations to fully adopt the technologies.
  • Lasso Security boasts a team of seasoned entrepreneurs, cyber innovators, and data scientists with decades of collective experience.

Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer

Retrieved on: 
Monday, October 16, 2023

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Manmeet S. Soni has been appointed as the Company’s Chief Operating Officer, effective immediately.

Key Points: 
  • Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Manmeet S. Soni has been appointed as the Company’s Chief Operating Officer, effective immediately.
  • “Manmeet Soni has few peers in this industry, and his track record speaks for itself,” stated Dr. Maky Zanganeh, Chief Executive Officer and President of Summit.
  • “Leveraging his leadership and wisdom on a daily basis is a powerful addition to the already formidable Team Summit.
  • I am grateful for the trust he has displayed in Maky, me, and our team in joining our mission full-time.”
    Mr. Soni has over 20 years of financial and operational leadership experience and joins Summit from Reata Pharmaceuticals, Inc., where he was President, Chief Operating Officer, & Chief Financial Officer.

FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising

Retrieved on: 
Monday, July 17, 2023

“Protecting competition in the emerging health care programmatic advertising market plays a critical role in lowering health care costs, including the cost of prescription drugs.” said FTC Bureau of Competition Director Holly Vedova.

Key Points: 
  • “Protecting competition in the emerging health care programmatic advertising market plays a critical role in lowering health care costs, including the cost of prescription drugs.” said FTC Bureau of Competition Director Holly Vedova.
  • Competition in this market is necessary to protect patients from higher health care prices that could be passed on if the cost of marketing health care products increases due to reduced competition.
  • As the largest health care data provider, IQVIA also plays a unique and critical role in programmatic advertising to health care professionals because it controls leading provider identity and prescribing behavior data that is essential for health care demand-side platforms to compete.
  • Because IQVIA’s datasets are considered the “gold standard” among health care industry participants, health care advertisers frequently prefer that demand-side platforms use IQVIA data in their programmatic advertising campaigns to health care professionals.

FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising

Retrieved on: 
Monday, July 17, 2023

“Protecting competition in the emerging health care programmatic advertising market plays a critical role in lowering health care costs, including the cost of prescription drugs.” said FTC Bureau of Competition Director Holly Vedova.

Key Points: 
  • “Protecting competition in the emerging health care programmatic advertising market plays a critical role in lowering health care costs, including the cost of prescription drugs.” said FTC Bureau of Competition Director Holly Vedova.
  • Competition in this market is necessary to protect patients from higher health care prices that could be passed on if the cost of marketing health care products increases due to reduced competition.
  • As the largest health care data provider, IQVIA also plays a unique and critical role in programmatic advertising to health care professionals because it controls leading provider identity and prescribing behavior data that is essential for health care demand-side platforms to compete.
  • Because IQVIA’s datasets are considered the “gold standard” among health care industry participants, health care advertisers frequently prefer that demand-side platforms use IQVIA data in their programmatic advertising campaigns to health care professionals.

Bragar Eagel & Squire, P.C. Is Investigating Reata, DLocal, Comerica, and Advance Auto Parts and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 20, 2023

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On May 10, 2023, Reata issued a press release announcing its financial results for the first quarter of 2023.
  • On this news, Reata's stock price fell $14.99 per share or 14.23%, to close at $90.38 per share on May 10, 2023.
  • faced in the first quarter to continue.” Advance Auto Parts further revealed that it was cutting its quarterly dividend by 84% “to provide enhanced financial flexibility.”
    For more information on the Advance Auto Parts investigation go to: https://bespc.com/cases/AAP

Bragar Eagel & Squire, P.C. Is Investigating Reata, Comerica, and DZS and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 10, 2023

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On May 10, 2023, Reata issued a press release announcing its financial results for the first quarter of 2023.
  • On this news, Comerica's stock fell $1.40 per share, or 3.59% to close at $37.59 per share on May 30, 2023.
  • Following this news, DZS stock price dropped as much as 30% in pre-market trading on June 1, 2023.

Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, June 5, 2023

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • On this news, Reata's stock price fell $14.99 per share or 14.23%, to close at $90.38 per share on May 10, 2023.
  • On this news, Comerica's stock fell $1.40 per share, or 3.59% to close at $37.59 per share on May 30, 2023.